Published 2023-07-01
“…Maria Elisa Mancuso,
1,2 Daniel Eriksson,3 Aletta Falk,3 Zalmai Hakimi,3 Piotr Wojciechowski,4,5 Marlena Wdowiak,4 Robert Klamroth6,7
1Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; 2Humanitas University, Pieve Emanuele, Milan, Italy; 3Swedish Orphan Biovitrum AB, Stockholm, Sweden; 4Creativ-Ceutical, Krakow, Poland; 5Assignity, Krakow, Poland; 6Department of Internal Medicine, Hemophilia Treatment Center, Vivantes Klinikum im Friedrichshain,
Berlin, Germany; 7Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, GermanyCorrespondence: Robert Klamroth, Department of Internal Medicine – Angiology and Hemostaseology, Center for Vascular Medicine, Haemophilia Treatment Center, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49,
Berlin, D-10249, Germany, Tel +49 (0)30 130 231575, Fax +49 (0)30 130 232130, Email robert.klamroth@vivantes.dePurpose: For patients with hemophilia B, extended half-life factor IX (FIX) products are available for prophylaxis and for treating bleeds. …”
Get full text
Article